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Background: Lichen sclerosus is a mucocutaneous autoimmune disease which might be initiated by infectious 
pathogens as Borrelia Bugrdorferi and HPV. This disease shows destructive potential and is rarely diagnosed in 
oral mucosa. The purpose of this paper is to evaluate the characteristics of cases described in literature from 1957 
to 2016, looking to provide valuable evidence about clinicopathologic features of this disease. 
Material and Methods: A MedLine search was performed aiming to find oral lichen sclerosus cases in literature 
and discuss its demographical and pathological characteristics as well as treatment methods performed for these 
cases. 
Results: 34 oral lichen sclerosus cases with histological confirmation and one clinicopathologic study linked with 
this disease were found in literature. Oral lichen sclerosus affected most commonly female patients, were asymp-
tomatic and not associated to skin or genital lesions. Furthermore, affected patients in a range of 7 – 70-years old 
(Average age = 31.81).
Conclusions: Oral lichen sclerosus is a rare pathologic process with slight predilection for prepubertal girls, for 
which topical corticosterois have demonstrated satisfactory therapeutic value.




In 1887 Hallopeau (1) described ‘lichen planus atrophi-
cus’ as a new pathologic process occurring in anogenital 
region. Latter in 1892, Darier (2) published histopatho-
logic features of a similar lesion named ‘lichen planus 
sclerosus’. Anyway, both lesions were considered varia-
tions of lichen planus (LP) by other researchers (3,4). 
Montgomery and Hill (5), in 1940, showed both lesions 
represented the same disease, with clinical and histo-
pathologic features distinct from LP and described this 
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disease as ‘lichen sclerosus et atrophicus’, which be-
came a misused term along the years, once not all lichen 
sclerosus are atrophic (4).
Lichen sclerosus (LS) is now described as an unusual 
mucocutaneous chronic inflammatory disease which 
predominantly involves the anogenital region and dem-
onstrates potential for resulting in atrophy, destructive 
scaring, functional impairment and malignant evolution 
(6). Therefore, early adequate diagnosis and either ther-
apeutic intervention or clinical follow-up are mandatory 
(6). Although anogenital skin and mucosa is the mostly 
affected region, in 15% to 20% of cases (4,7,8) patients 
might be committed by extragenital lesions, and the 
oral mucosa is an extremely rare site for LS lesions oc-
currence (8-11), while only 6% of cases are represented 
by isolated extragenital lesions (6). Besides LS shows 
a slight predilection for prepubertal girls and pre and 
postmenopausal women, individuals at any age may 
be affected (6), as well as male individuals. To define 
any prevalence rate for LS lesions occurring in mouth 
is challenging, since, as previously mentioned, this ana-
tomical site is rarely affected by LS lesions (4,11-14).
Although LS have been described as an autoimmune 
disease, factors which might initiate atypical immuno-
logic response in skin and mucosas have not been well 
defined. Among factors which have been discussed as 
possible causes for LS, besides factors inherent to the 
patient, as individual diathesis and hormonal variations, 
environmental factors include trauma and an emerging 
infectious agent in Brazil associated to Lyme disease 
and morphea (Borrelia Burgdorferi) (6,11). Moreover, 
human papillomavirus (HPV) have been studied, and 
some authors suggests this virus might be responsible 
for a percentage of anogenital LS cases (15).
Clinically, anogenital LS is typically characterized by 
well demarcated whitish plaques which might be slight-
ly raised or flat lesions and vary from small localized 
macula to extensive lesions involving larger areas of 
mucosa and skin (11). As shown in Figure 1, oral LS 
demonstrates these same clinical features described for 
anogenital LS. Patients with anogenital LS lesions usu-
ally relate soreness and pruritus, while these symptoms 
are less common in extragenital lesions (6). Diagnosis 
of LS is only obtained by histologic evaluation, since 
clinically, differential diagnosis for this disease includes 
whitish plaque lesions, as well as LP and vitiligo (6,16). 
Histopathologic features typically found for LS lesions 
include either variable epithelial atrophy or hyperplasia, 
focal hydropic degeneration of basal cells, a band of sub-
epithelial hyalinization and a slightly diffuse band-like 
lymphocytic infiltrate beneath hyalinized collagen area 
(11,12). Both lichen planus and vitiligo lack the subepi-
thelial hyalinized area, and furthermore, melanocytes 
presence excludes vitiligo hypothesis (6).
Regarding treatment, LS is a chronic disease with no 
cure and no available either systemic or local effective 
therapy; although, treatment can relive symptoms and 
improve aesthetic aspects. Oral lesions have been suc-
cessfully treated either by topical corticosteroids ad-
ministration or surgical excision (4,13,17,18). 
Given that LS is greatly rare in oral mucosa, to perform 
researches aiming to describe demographic and clini-
copathologic characteristics of this disease with oral 
manifestation becomes challenging, therefore, in this 
paper we critically analyzed the few cases described in 
literature aiming to provide scientific valuable data re-
garding LS of the oral mucosa. 
Material and Methods
This study was performed through search in MedLine 
database searching for papers reporting oral LS cases 
with histological diagnosis confirmation from 1957 to 
Fig. 1. Clinical aspect of oral LS. (A) White rounded stain in lower lip vermilion with no surface alteration. (B) Extension of the lesion 
to lower lip mucosa.
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2016 on English literature (Table 1). To analyze these 
cases, we extracted from each paper data regarding age, 
sex, symptomatic manifestation of the lesion, presence 
of skin lesions and presence of anogenital lesions. As 
the characteristics that we aimed to evaluate were not 
available for all cases, percentages are presented based 
on the total of cases which had each variable informa-
tion available.
Results
In our search, we found 34 cases of oral LS with his-
topathologic confirmation of the diagnosis (Table 1). 
Analysis of these cases is summarized in Table 2. Our 
critical analysis showed high age variability, ranging 
from 7 to 70 years old, while the average age was 31.81. 
Females individuals were clearly more affected (61.73%) 
by oral LS than male individuals (38.23%), and in most 
of cases, symptomatic manifestation of the lesions was 
not present. Furthermore, in only 33.33% of the cases, 
oral lesions were associated to skin lesions, and in only 
16.12% of the cases oral LS lesions were associated to 
genital lesions. Duration of the lesions varied from 20 
days to 2 years and the most commonly affected site 
was the lip (vermilion and mucosa).
Discussion
The term lichen sclerosus (LS) describes a chronically 
relapsing dermatosis with potential to result in destruc-
tive scaring, atrophy, functional impairment, and ma-
lignant transformation, which predominantly affects 
anogenital mucosa and skin (6,11,16). As demonstrated 
in our review, oral manifestation of LS is an extremely 
rare condition, with 34 histologically confirmed cases 
reported since 1957, when Miller (16) and Ravits and 
Welsh (19) published the first papers describing oral LS 
cases (Table 1).
In review performed by Fistarol & Itin (6), the authors 
reported anogenital LS is clearly more frequent among 
female patients compared to male patients and shows 
a remarkable predilection for prepubertal girls and 
post-menopausal women. Recently, Knio et al. (20) 
demonstrated in clinicopathologic study that among 60 
patients with LS (genital and extragenital) 70% were 
women. Attili and Attili (21) did not found predilection 
for any gender in a clinicopathologic study of lips LS, 
however, we observed that oral LS demonstrated a slight 
predilection for the female gender (Table 2). In addition, 
we also noted that oral LS shows high age variability, 
occurring in patients from 7 to 70-years old (Table 2). 
Although LS occurrence in the anogenital mucosa and 
skin have been reported as more frequent in young girls 
and post-menopausal women, we found no predilection 
for any age in our review. 
Clinical features of skin and anogenital LS include 
white stains which might be slightly elevated or flat, 
with well demarcated limits and variable shape (6). In 
our 34 reported cases review the lesions’ characteristics 
described, specially size, color and shape, do not differ 
from skin and anogenital LS characteristics. However, 
further diseases, as well as LP, vitiligo and oral leuko-
plakia (OL) must be considered on the differential diag-
nosis of LS. Macleod and Soames (22) reported a case 
of oral LS in comorbity with vitiligo. Therefore, histo-
pathologic analysis of biopsy specimens is required for 
obtaining the diagnosis of LS (6,11). In general, histo-
pathologic characteristics of oral LS are not highly dif-
ferent from the characteristics of skin and anogenital 
LS. Knio et al. (20) indicated genital LS lesions were 
more likely to present epithelial hyperplasia, while ex-
tragenital lesions were mostly associated to epithelial 
atrophy. However, the main histologic feature of LS is 
the band of hyalinized collagen fibers immediately be-
low the epithelium, which might show variable density, 
organization and thickness. Furthermore, a band-like 
inflammatory infiltrate is found below the hyalinized 
area. It is suggested that the inflammation begins near 
to the epithelium, leading to destruction and reorganiza-
tion of collagen fibers and leaving conjunctive sclerosis 
as it deepens into the tissue. Thus, older lesions of LS 
will present thicker band of hyalinized collagen while in 
lesions with short period of evolution this hyalinization 
band are thinner (6).
Literature shows in only about 6% of LS cases, lesions 
occurs in extragenital isolated sites (6). Oral LS most 
commonly occurred isolate, since in only 11 (33.33%) 
cases oral LS occurred associated to skin lesions and in 
only 5 cases (16.12%) oral LS was associated to genital 
lesions (Table 2), suggesting skin lesions are more com-
monly associated to genital lesions, while oral lesions 
tend to occur isolate.
The etiology of LS was not well defined, but there is a gen-
eral agreement regarding the auto-immune nature of this 
disease (6,11); more specifically, anogenital lesions have 
been associated to extracellular matrix 1 (ECM1) protein 
destructions, which may be mediated by circulating IgG 
antibodies and, furthermore, might also be associated to 
ECM1 autoreactivity (6,14). ECM1 protein develops an im-
portant role on the control of keratinocyte differentiation 
within epidermis, whereas within dermis ECM1 is impor-
tant for structural organization (23). Xavier et al. (14) de-
scribed an oral LS case in which molecular tests suggested 
extracellular matrix reorganization, elastic fibers reduction 
and altered proteolytic activity, however, the cause of this 
reorganization was not investigated. Moreover, anogenital 
LS has also been associated to patient diathesis, and trig-
gering factors which may lead to LS occurrence include 
trauma and chronic irritation, hormonal influences and in-
fectious pathogens such as Borrelia Burgdorferi, EBV and 
HPV, leading some authors to describe LS as a multifacto-
rial disease (6,11,24,25).

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Range 7 – 70
Average 31.81
Table 2. Characteristics of oral lichen sclerosus cases re-
ported from 1957 to 2016.
In a case reported by George et al. (26), Borrelia Burg-
dorferi was identified by Focus-Floating microscopy. 
Borrelia Burgdorferi is the cause of the Lyme Borrelio-
sis, which has the LS as the most common skin condi-
tion associated (27), deserving attention from the health 
care professionals. Moreover, it was demonstrated Bor-
relia Burgdorferi has the potential to induce collagen 
and elastic fibers alterations, which is the main histo-
pathologic finding of LS lesions (27).
The association of HPV to anogenital LS have been de-
scribed in variable percentage rates by several authors. 
In 1991, Kiene et al. (28), by polymerase chain reaction 
(PCR) technique of paraffin embedded biopsy specimens 
of LS of the vulva observed that HPV-16 was present in 4 
out of 18 samples, however this study only evaluated the 
presence of HPV-16 while further genotypes of the virus 
could be present in the specimens. Nasca et al. (25) indi-
cated 17.4% of 46 patients with penile LS were positive to 
HPV infection by brush cytology of the lesions. Prowse et 
al. (29), found a higher HPV prevalence of 33% among 20 
patients with penile LS. HPV presence was not investigat-
ed in any of the 34 cases of oral LS included in our review, 
demonstrating that there is no available data regarding the 
association of HPV and oral LS, suggesting the need for 
further investigations in future cases and studies.
Most of cases found in literature had the lips committed 
by LS (Table 1), but factors which might initiate an inflam-
matory response leading to this autoimmune reaction in 
this site have not been discussed. We believe this might be 
explained by the fact that the lips are the mouth sites most 
susceptible to linear environmental stimuli, as infectious 
pathogens and trauma (Köbner phenomenon), however, 
the etiology of oral LS is still subject for investigation.
Anogenital LS is known to possibly result in loss of tis-
sue function and structure when diagnosed and treated 
in advanced stages (6,11). Jiménez et al. (30), described 
an oral LS case with upper lip, buccal sulcus and gin-
giva involvement which in the lesion resulted in severe 
destruction of periodontal structures, with loss of bone 
tissue and dental mobility. Later, in 2008, the same team 
described another case of oral LS with severe gingival 
recession (31). These cases highlight oral LS lesions 
may present the destructive behavior reported for ano-
genital lesions, therefore, early diagnosing and treating 
these lesions might prevent significant structural losses 
and functional impairment.
Transformation of anogenital LS into squamous cell car-
cinoma (SCC) is subject of debate in literature. Although 
data regarding this transformation remains highly incon-
sistent, increased risk for anogenital SCC development in 
patients with anogenital LS is evident. Malignant trans-
formation of vulvar LS rates varies from 1.4% to 61% 
and from 4% to 8% for penile LS, however, 32% - 50% 
of SCC of the penis demonstrate histologic findings sug-
gestive of LS (15). Nevertheless, factors associated to 
malignant transformation of anogenital LS are not well 
elucidated. HPV infection was associated to variable 
percentages of genital LS which transformed into SCC, 
although, the presence of vulvar intraepithelial neopla-
sia (VIN) in vulvar LS seems to be more strongly as-
sociated to this transformation and the presence of HPV 
in this process might be a chance occurrence event per 
some authors (15). In 2011, Regauer (32) demonstrated 
that the persistence of LS lesions after surgical removal 
of anogenital SCC was associated to a recurrence rate of 
50%. Moreover, Bleeker et al. (33), indicated a concur-
rent association between advanced age (>70 years-old) 
and VIN in the malignant transformation of LS of the 
vulva. Thus, the potential of anogenital LS to transform 
into SCC requires further investigation, including the 
role of the HPV in this process. In our review, no cases of 
oral LS were reported with transformation into SCC until 
this moment, which anyway does not exclude the need 
for early diagnosing and treating LS in mouth.
Treatment approaches for LS generally aims to release 
symptoms, to prevent tissue destruction and to improve 
cosmetic aspects, given that there is no available effec-
tive therapy and cure for this disease (1,6). Although 
anogenital LS lesions are commonly symptomatic, pre-
senting soreness and pruritus, most of oral LS cases 
described were asymptomatic (67.85%), which might 
represent a worrisome fact for the clinician, since the 
asymptomatic development of a disease does not aware 
the patient to early look for professional care. Anogeni-
tal lesions of LS used to be treated with testosterone ap-
plications; nevertheless, this approach became misused 
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due to lacks in effectiveness and hormonal instabilities 
in female patients (6). Surgical excision is reliable for 
small oral and vulvar LS lesions (11). We found that 4 
out of 34 oral LS described cases were surgically ex-
cised (Table 1), leading to symptoms reduction and no 
recurrence (11,14,18). Local administration of corticos-
teroids has been reported with high success rates for 
anogenital lesions (6), whereas oral LS cases reported in 
literature were mostly treated by local administration of 
corticosteroids with satisfactory success (8,34-38). Tri-
amcinolone have shown good results for the treatment 
of anogenital LS (6), and several authors who reported 
oral LS cases in literature described local administra-
tion of triamcinolone as treatment with satisfactory 




LS is an uncommon and distinct autoimmune condition 
with rare oral manifestation, therefore, scientific evi-
dence regarding sociodemographic and clinicopathologic 
characteristics of oral LS lesions are difficult to estab-
lish. Nevertheless, data extracted from few cases found 
in literature allow to elucidate that some characteristics 
of these lesions might corroborate with characteristics 
described for skin and anogenital lesions regarding etio-
logic factors, pathogenesis and therapeutic approaches.
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